Just another article on the Tanzanian Govt's 4th licencing round.The article was linked to Exxon's development strategy.http://mobile.reuters.com/article/idUSL5N0IF2AH20131025?irpc=932
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%